Reuters logo
BRIEF-Vertex Pharmaceuticals says cystic fibrosis combo succeeds in late stage trials
June 24, 2014 / 11:13 AM / 3 years ago

BRIEF-Vertex Pharmaceuticals says cystic fibrosis combo succeeds in late stage trials

June 24 (Reuters) - Vertex Pharmaceuticals -

* Vertex Pharmaceuticals says cystic fibrosis combo of kalydeco and lumacaftor succeeds in late stage trials

* Vertex Pharmaceuticals says combo improved lung function in patients with most common genetic mutation associated with rare lung disease

* Vertex Pharmaceuticals says would file applications for U.S. And european approval for the combo in Q4 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below